Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

       Date of Report (Date of earliest event reported): February 1, 2008

                           CHINA PHARMA HOLDINGS, INC.

             (Exact name of registrant as specified in its charter)

           Delaware                000-29523            73-1564807
(State or other jurisdiction     (Commission         (IRS Employer
      of incorporation)          File Number)    Identification Number)

         2nd Floor, No. 17, Jinpan Road, Haikou, Hainan Province, China,
                    (Address of principal executive offices)

                            0086-898-66811730 (China)
              (Registrant's telephone number, including area code)

          (Former Name or Former Address if changed Since Last Report)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

[ ]  Written  communications  pursuant to Rule 425 under the  Securities Act (17
     CFR 230.425)

[ ]  Soliciting  material pursuant to Rule 14a-12 under the Exchange Act (17 CFR

[ ]  Pre-commencement   communications  pursuant  to  Rule  14d-2(b)  under  the
     Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement   communications  pursuant  to  Rule  13e-4(c)  under  the
     Exchange Act (17 CFR 240.13e-4(c))

ITEM 5.02  Departure of Directors or Certain  Officers;  Election of  Directors;
           Appointment of Certain Officers.

Paragraph (b) of Item 502.


On  February  1, 2008,  China  Pharma  Holdings,  a Delaware  Corporation,  (the
"Company")  announced  the  resignation  of Heung  Mei  TSUI as a member  of the
Company's Board of Directors, effective February 1, 2008. Ms. TSUI, who has been
a member of the  Company's  Board of Directors  since  October 20, 2005,  had no
disagreement  with the Company and a copy of her resignation  letter is attached
hereto as Exhibit 99.1 to this Report and incorporated by reference herein.

Pargraph (d) of Item 502.

On  February  1, 2008,  the Board  expanded  the number of seats on the Board of
Directors and appointed three independent directors. G. Michael Bennett, Yingwen
Zhang and Baowen Dong.  These three  directors  will all serve on the  Company's
Audit Committee. Following are the primary background of three Directors:

G. Michael  Bennett is a CPA, who graduated from Michigan  State  University and
University of Michigan.  He currently is a DBA candidate in Corporate Governance
at City  University  of Hong Kong.  He acted as CFO and Board Member in National
Automobile Club from 1983 to 1986. After that, he worked as an accounting,  tax,
and audit professor in California State  University from 1986 to1989,  and as an
accounting  and audit  professor  in Chapman  University  from 1989 to 1993.  He
served as the CFO and Board  Member in  Argonaut  Computers  from 1993 to1998 in
Southern of California. During 1998-2000, he was a basic law, accounting and tax
professor in University  of Hawaii and  accounting,  tax and audit  professor in
Chaminade  of  Honolulu.  He acted  as a  partner  of  ProCFO  Company  based in
California which provided  contract CFO service for firms during  2000-2004.  He
was also a partner of Nexis Investment  Consulting  Corporation based in Beijing
during 2004-2007.

Yingwen  Zhang is graduated  from  Department of Chemical  Engineering,  Tianjin
University in 1967. He worked as the CEO of SINOPEC  SICHUAN  VINYLON WORKS from
1983 to 1988 and worked as the  director of Sichuan  Foreign  Trade and Economic
Cooperation  Bureau (The Bureau of Commerce of Sichuan  Province) from December,
1988 to April 2000.  Since then,  he has acted as the  Economic  and  Commercial
Counselor's Office of the Embassy of the People's Republic of China in Malaysia.
Mr.  Zhang  currently  is the  member  of the  9th  Chinese  People's  Political
Consultative Conference (CPPCC).

Baowen Dong is graduated from Xian University of Science and Technology in 1966.
He is the professor, researcher, director of the staff room, and the department
head in Sichuan University since 1974. He is also an expert member of the
Sichuan University Teaching Evaluation Council since August 2001.

ITEM 9.01 Financial Statements and Exhibits

     (d)  Exhibits

     99.1     Resignation Letter dated February 1, 2008



Pursuant to the  requirements  of the  Securities  and Exchange Act of 1934,  as
amended,  the  registrant has duly caused this report to be signed on its behalf
by the undersigned hereto duly authorized.

Date:  February 4, 2008                 CHINA PHARMA HOLDINGS, INC.,
                                        a Delaware corporation

                                        By:  /s/ Zhilin Li
                                        Title:  Chief Executive Officer